Tag: Aquavit Pharmaceuticals

All

Aquavit Files Investigation of New Drug for New Botulinum Toxin

Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.

All

Sorry, No Posts Found

All

How Evolysse Could Change the HA Filler Market: Insights from Dr Rami Batniji

Dr Rami Batniji discusses how Evolysse’s cold technology manufacturing process may offer clinical advantages over traditional hyaluronic acid fillers.

Understanding the Rise in Male Facial Plastic Surgery: Insights from AAFPRS President Patrick Byrne
Facial Plastic Surgeons Treat Patients With War-related Injuries in Ukraine
New Approach Could Help Prevent Scarring After Surgery

Tag: Aquavit Pharmaceuticals

All

Aquavit Files Investigation of New Drug for New Botulinum Toxin

All

Sorry, No Posts Found

All

How Evolysse Could Change the HA Filler Market: Insights from Dr Rami Batniji

Understanding the Rise in Male Facial Plastic Surgery: Insights from AAFPRS President Patrick Byrne

Facial Plastic Surgeons Treat Patients With War-related Injuries in Ukraine

New Approach Could Help Prevent Scarring After Surgery

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links